abstract |
The present invention relates to parenteral formulations for certain long chain saturated and monounsaturated fatty acid derivatives of 1-β-D-arabinofuranosylcytosine (cytarabine). In particular, the present invention relates to parenteral pharmaceutical compositions and methods for their preparation to accommodate therapeutically effective doses of the above derivatives that improve compliance in the treatment of cancer. |